AstraZeneca shares plunged Monday on news that the drugmaker was exploring an acquisition of Bristol Meyers Squibb. A deal would create one of the world's biggest drugmakers. Sam Fazeli of Bloomberg Intelligence says a takeover would make no sense. (Source: Bloomberg)
AstraZeneca shares plunged Monday on news that the drugmaker was exploring an acquisition of Bristol Meyers Squibb. A deal would create one of the world's biggest drugmakers. Sam Fazeli of Bloomberg Intelligence says a takeover would make no sense. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/990145b903e79eb40ee4e2240dd85dd9a9dce5e0" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Astra Buying Bristol Makes No Sense, Fazeli Says"></iframe>
